Home   /   Taxonomy   /   Term

Acumen Diagnostics

CGS-CIMB updates Q&M to 'add' as Acumen's tender win alleviates short-term pressure - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB updates Q&M to 'add' as Acumen's tender win alleviates short-term pressure

"We believe valuations have turned attractive for Q&M": CGS-CIMB as their FY2023 earnings note negligible contribution from Acumen
Q&M Dental banks on AI tech after Covid-19 high - THE EDGE SINGAPORE

Corporate moves

Q&M Dental banks on AI tech after Covid-19 high

Q&M is coming off its Covid-19 high, but it intends to ride on another boom.

Broker's Calls

CGS-CIMB expects earnings momentum to ease for Q&M; valuation remains attractive

Q&M's earnings growth momentum is expected to ease but at 15.2 times P/E and a dividend yield of 7%, the stock is still attractive
Q&M Dental Group: Outlook bright with expansion and a spin-off - THE EDGE SINGAPORE

Stocks To Watch

Q&M Dental Group: Outlook bright with expansion and a spin-off

Bright smiles ahead for Q&M Dental Group.

Broker's Calls

Potential listing of Acumen on Nasdaq may boost Q&M and Aoxin Q&M: UOBKH

Acumen's potential listing on Nasdaq bodes well for both Aoxin Q&M and Q&M Dental.

Covid-19

Q&M's Acumen Diagnostics granted MOH Covid-19 offsite PCR testing license

PCR testing services will be rolled out to 10 clinics by Dec 31.
Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant - THE EDGE SINGAPORE

Covid-19

Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant

This is in addition to being able to detect Covid-19 cases infected with the Delta variant, says the group.
Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil - THE EDGE SINGAPORE

M&A

Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil

Q&M, which owns a 32.95% stake in Aoxin Q&M, will have effective ownership of 67.15% in Acumen post-transaction.
UOB Kay Hian starts Q&M Dental at 'buy' on twin growth engines and Covid-19 testing business - THE EDGE SINGAPORE

Broker's Calls

UOB Kay Hian starts Q&M Dental at 'buy' on twin growth engines and Covid-19 testing business

UOB Kay Hian's target price of 94 cents is pegged to 20 times FY2022 price-to-earnings (P/E).
Q&M’s Acumen receives approval from MOH to provide offsite Covid-19 testing - THE EDGE SINGAPORE

Covid-19

Q&M’s Acumen receives approval from MOH to provide offsite Covid-19 testing

Shares in Q&M closed 1 cent lower or 1.4% down at 68 cents on June 4.
×